bexarotene has been researched along with Neuroblastoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, LA; Ashton, JM; Battaglia, N; Dokholyan, NV; Fujihara, M; Gerber, SA; Hansen, JN; Hopson, R; Jian, Y; Jurutka, PW; Kakuta, H; Kawar, N; Khazan, N; Kim, KK; Kishor, K; Linehan, DC; Milano, MT; Miyamoto, H; Moore, RG; Moore, T; Nayak, S; Ojha, D; Pandita, R; Rowswell-Turner, RB; Schor, NF; Sharon, A; Singh, AP; Singh, NA; Singh, RK; Snyder, CWA; Strawderman, M; Tabdanov, ED; Takamura, Y; Teramoto, Y; Wang, J; Yano, N | 1 |
| Adamkova, K; Chlapek, P; Dobrotkova, V; Jezova, M; Mazanek, P; Sterba, J; Veselska, R | 1 |
| Hewson, QC; Lovat, PE; Pearson, AD; Redfern, CP | 1 |
| DiPette, D; Guleria, R; Joshi, S; Pan, J; Singh, US | 1 |
| Hewson, QC; Irving, H; Lovat, PE; Malcolm, AJ; Pearson, AD; Redfern, CP | 1 |
| Hewson, QC; Lova, PE; Malcolm, AJ; Pearson, AD; Redfern, CP | 1 |
6 other study(ies) available for bexarotene and Neuroblastoma
| Article | Year |
|---|---|
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors
Topics: Animals; Animals, Genetically Modified; Heterografts; Humans; Neuroblastoma; Receptors, Calcitriol; Vitamins | 2022 |
Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
Topics: Adolescent; Antineoplastic Agents; Bexarotene; Biomarkers, Pharmacological; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; DEAD-box RNA Helicases; Drug Resistance, Neoplasm; Female; Fenretinide; HMGA1a Protein; HMGA2 Protein; Homeodomain Proteins; Humans; Infant; Infant, Newborn; Isotretinoin; Male; Nervous System Neoplasms; Neuroblastoma; Paraffin Embedding; Pre-B-Cell Leukemia Transcription Factor 1; Tissue Fixation; Tretinoin; Young Adult | 2019 |
Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Topics: Alitretinoin; Bexarotene; Dose-Response Relationship, Drug; Gene Expression; Humans; Neuroblastoma; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; RNA, Messenger; Signal Transduction; Tetrahydronaphthalenes; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 2002 |
Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Topics: Alitretinoin; Antineoplastic Agents; Bexarotene; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Humans; Kidney; Neoplasm Invasiveness; Neuroblastoma; Protein Glutamine gamma Glutamyltransferase 2; Receptors, Retinoic Acid; Retinoid X Receptors; Signal Transduction; Tetrahydronaphthalenes; Transglutaminases; Tretinoin | 2006 |
Retinoid-induced differentiation of neuroblastoma: comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid.
Topics: Antineoplastic Agents; Bexarotene; Blotting, Northern; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Gene Expression; Humans; Neuroblastoma; Tetrahydronaphthalenes; Tretinoin | 1998 |
Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells.
Topics: Alitretinoin; Bexarotene; Cell Differentiation; Cell Division; Dimerization; Humans; Neuroblastoma; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Tetrahydronaphthalenes; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 2000 |